For example, the lack of sensitivity of some triple-negative breast cancer cells may reflect both a decreased dependence on CDK4/6 activity for cell cycle entry (due to high cyclin E expression and CDK2 activity) and low p21 and/or p27 levels [68]. This evidence concerns the gene CDKN1B and triple-negative breast carcinoma.